SE8802505L - Contraceptive method - involving determination of presence of progesterone or its metabolites in urine or saliva - Google Patents
Contraceptive method - involving determination of presence of progesterone or its metabolites in urine or salivaInfo
- Publication number
- SE8802505L SE8802505L SE8802505A SE8802505A SE8802505L SE 8802505 L SE8802505 L SE 8802505L SE 8802505 A SE8802505 A SE 8802505A SE 8802505 A SE8802505 A SE 8802505A SE 8802505 L SE8802505 L SE 8802505L
- Authority
- SE
- Sweden
- Prior art keywords
- progesterone
- metabolites
- urine
- saliva
- contraceptive method
- Prior art date
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000002207 metabolite Substances 0.000 title abstract 2
- 229960003387 progesterone Drugs 0.000 title abstract 2
- 239000000186 progesterone Substances 0.000 title abstract 2
- 210000002700 urine Anatomy 0.000 title abstract 2
- 239000003433 contraceptive agent Substances 0.000 title 1
- 230000002254 contraceptive effect Effects 0.000 title 1
- 210000003296 saliva Anatomy 0.000 title 1
- 238000012360 testing method Methods 0.000 abstract 2
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000016087 ovulation Effects 0.000 abstract 1
- 230000027758 ovulation cycle Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A new method for deciding a woman's safe period during the menstrual cycle by showing that ovulation has occurred, particularly involving testing urine or salvia for progesterone or its metabolites. The method is used as a birth control utilising the safe period. A rapid test by chemical or immunological methods is particularly claimed. (Provisional Basic previously advised in week 9009).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8802505A SE8802505L (en) | 1988-07-05 | 1988-07-05 | Contraceptive method - involving determination of presence of progesterone or its metabolites in urine or saliva |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8802505A SE8802505L (en) | 1988-07-05 | 1988-07-05 | Contraceptive method - involving determination of presence of progesterone or its metabolites in urine or saliva |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8802505D0 SE8802505D0 (en) | 1988-07-05 |
| SE8802505L true SE8802505L (en) | 1990-01-06 |
Family
ID=20372816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8802505A SE8802505L (en) | 1988-07-05 | 1988-07-05 | Contraceptive method - involving determination of presence of progesterone or its metabolites in urine or saliva |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE8802505L (en) |
-
1988
- 1988-07-05 SE SE8802505A patent/SE8802505L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE8802505D0 (en) | 1988-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Whitehead et al. | The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease | |
| Rock et al. | Cul-de-sac fluid in women with endometriosis: fluid volume and prostanoid concentration during the proliferative phase of the cycle—days 8 to 12 | |
| GB8730100D0 (en) | Immunoassay/diagnostic device & method of manufacture | |
| ES2042725T3 (en) | PROCEDURE FOR PREPARING 5-ALPHA-ESTERSA STEROID INHIBITORS. | |
| ES8307899A1 (en) | Method for the detection of human occult blood in human stool samples. | |
| CA2142264A1 (en) | Monitoring method | |
| DE69308148D1 (en) | METHODS FOR CONCEPT PREVENTION AND TEST KITS FOR THEIR IMPLEMENTATION | |
| ES8500039A1 (en) | Method and apparatus for detection of fertility. | |
| AU5142193A (en) | Method for prediction of premature labor | |
| DE69308146D1 (en) | MONITORING PROCEDURE | |
| SE8701905D0 (en) | A METHOD AND A KIT FOR THE DIAGNOSIS OF IGA NEPHROPATHY | |
| GB8901859D0 (en) | Diagnostic test | |
| Bonnar et al. | Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices | |
| SE8802505L (en) | Contraceptive method - involving determination of presence of progesterone or its metabolites in urine or saliva | |
| AU8001598A (en) | Ovulation methods, devices and test kits for monitoring | |
| DE3266445D1 (en) | Home diagnostic aid and method for determining the presence of occult blood for use by the general public | |
| JPS6438657A (en) | Solid phase antibody for immunoassay | |
| Obiekwe et al. | Placental protein 5: circulating levels in twin pregnancy and some observations on the analysis of biochemical data from multiple pregnancy | |
| Karim et al. | Menstrual induction--termination of early pregnancy with a new prostaglandin analogue SHB 286 | |
| AHMED et al. | Concomitant secretion of Schwangerschaftsprotein 1 and human chorionic gonadotrophin following conception | |
| JPS5228928A (en) | Immunochemical reagent and process for its preparation | |
| Tauber et al. | Effects of a new antiovulatory steroid on gonadotropins, prolactin and blood coagulation | |
| JPS5244229A (en) | Method of making serological reagent for syphilis | |
| Duncan | Beta-thromboglobulin levels and oral contraception | |
| Li et al. | Outpatient endometrial biopsy: clinical, endocrinologic and histologic consequences |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8802505-1 Effective date: 19930201 Format of ref document f/p: F |